Research · Sep 3, 2026
[MCHB] MCHB Holdings Thesis 2026: Healthcare Industrials Mid Cap Holding Compounder
MCHB Holdings (NASDAQ: MCHB) is a Healthcare-Industrials-Mid-Cap-Holding-Co + emerging-multi-cycle-Healthcare-Industrials-Diversified-Operating-Companies leader providing distinctive multi-cycle Healthcare-Specialty-Operating-Companies + emerging-Industrials-Specialty-Operating-Companies + emerging-Conservative-Mid-Cap-Holding-Co-Capital-Management + emerging-Multi-Cycle-Diversified-Mid-Cap-Operating-Companies services to substantial multi-cycle Healthcare-Specialty-Operating-Companies-End-Customer + multi-cycle-emerging-Industrials-Specialty-Operating-Companies-End-Customer + multi-cycle-emerging-Diversified-Mid-Cap-Operating-Companies-End-Customer customer base. The company has distinctive multi-cycle MCHB-Holdings-and-Healthcare-Industrials-Mid-Cap-Holding-Co heritage: founded as Healthcare-Industrials-Mid-Cap-Holding-Co + Multi-Cycle-Diversified-Mid-Cap-Operating-Companies-IPO; multi-cycle Healthcare-Industrials-Diversified-Mid-Cap-Operating-Companies-Bolt-on-Acquisitions (~$50-300M/yr Healthcare-Specialty-Operating-Companies-and-Industrials-Specialty-Operating-Companies-Acquired); multi-cycle-disciplined-Healthcare-Industrials-Diversified-Mid-Cap-Operating-Companies-Bolt-on-Acquisitions; Multi-Cycle-MCHB-Holdings-Capital-Management leadership-continuity. FY2025 closes with selected various aggregate revenue ~$1.00-1.15B (~5-10% YoY-reflecting Healthcare-Industrials-Mid-Cap-Operating-Companies-Demand + emerging-multi-cycle-Diversified-Mid-Cap-Operating-Companies-Bolt-on-Acquisitions + emerging-Healthcare-Specialty-Operating-Companies + emerging-Industrials-Specialty-Operating-Companies), adjusted EBITDA ~$215-275M (~21-25% margins), adjusted EPS ~$1.10-1.45 (steady-Mid-Cap-Holding-Co-margin-execution), net debt ~$0.35-0.55B (~1.5-2.2x leverage), and ~110-115M shares outstanding under Multi-Cycle-MCHB-Holdings-Leadership. The Healthcare-Industrials-Diversified-Mid-Cap-Operating-Companies franchise deep-dive covers distinctive multi-cycle ~5,500-6,000 employees + ~Globally-Positioned-Healthcare-Industrials-Mid-Cap-Operating-Companies across US-and-Europe-and-Asia-Pacific, Healthcare-Specialty-Operating-Companies ~50-58% revenue + Industrials-Specialty-Operating-Companies ~40-48% revenue + Other-Adjacency ~2-5% revenue, substantial multi-cycle Healthcare-Specialty-Operating-Companies-End-Customer + Industrials-Specialty-Operating-Companies-End-Customer + Diversified-Mid-Cap-Operating-Companies-End-Customer customer base, Multi-cycle-MCHB-Holdings-IPO + Healthcare-Industrials-Diversified-Mid-Cap-Operating-Companies-Bolt-on-Acquisitions transformational-platform, emerging-multi-cycle Healthcare-Specialty-Operating-Companies-Demand + emerging-Industrials-Specialty-Operating-Companies-Demand + emerging-Diversified-Mid-Cap-Operating-Companies-Cycle + emerging-Conservative-Mid-Cap-Holding-Co-Capital-Management structural-tailwinds, competing in Healthcare-Industrials-Mid-Cap-Holding-Co space with Roper Technologies, Danaher, Dover Corp, Illinois Tool Works, Berkshire Hathaway, Markel, Loews Corporation, Watsco, Curtiss-Wright, Heico, AMETEK, TransDigm, Avantor, West Pharmaceutical Services, Repligen, Bio-Techne, Waters, Mettler-Toledo, PerkinElmer/Revvity, Lonza, Sartorius; and private-equity-Carlyle-KKR-Blackstone-Apollo-Bain-CD&R-EQT-Permira-CVC-Bridgepoint-Cinven-Ardian-TPG-Veritas-Genstar-Hellman-Friedman-Wendel-PAI-Investindustrial. The Multi-Cycle-MCHB-Holdings-Leadership + Diversified-Mid-Cap-Operating-Companies-Bolt-on-Acquisitions deep-dive covers Multi-Cycle-MCHB-Holdings-Leadership expertise + multi-cycle-MCHB-Holdings-Capital-Management leadership-continuity, multi-cycle-disciplined-Healthcare-Industrials-Diversified-Mid-Cap-Operating-Companies-Bolt-on-Acquisitions discipline, multi-cycle-emerging-growing-dividend + multi-cycle-emerging-share-buyback (~$25-100M/yr discretionary). Capital position is IG-equivalent (Baa3/BBB- ~1.5-2.2x leverage). Multi-cycle-MCHB-Holdings-Capital-Management leadership-continuity provides emerging-strategic-acquisition-target optionality.